Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| CFD-H5256 | Human | Human Complement Factor D / CFD Protein, Fc Tag |  |
|
|
| CFD-R5255 | Rhesus macaque | Rhesus macaque Complement Factor D / CFD Protein, Fc Tag |  |
|
|
| CFD-R52H3 | Cynomolgus / Rhesus macaque | Rhesus macaque / Cynomolgus Complement Factor D / CFD Protein, His Tag (active enzyme) |  |
|
|
| CFD-H52H8 | Human | Human Complement Factor D / CFD Protein, His Tag (active enzyme) |  |
|
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| ACH-5548 | ACH-5548; ACH-0145548 | Phase 1 Clinical | Achillion Pharmaceuticals Inc | Autoimmune Diseases | Details |
| BCX-9930 | BCX-9930 | Phase 2 Clinical | Biocryst Pharmaceuticals Inc | Hemoglobinuria, Paroxysmal; Glomerulonephritis, IGA; Glomerulonephritis, Membranous; Glomerulonephritis | Details |
| Vemircopan | ACH-0145228; ACH-5228; ALXN-2050 | Phase 2 Clinical | Achillion Pharmaceuticals Inc | Myasthenia Gravis; Glomerulonephritis, IGA; Hemoglobinuria, Paroxysmal; Kidney Diseases; Lupus Nephritis; Hepatic Insufficiency | Details |
| Danicopan | ACH-4471; ACH-0144471; ALXN-2040 | Phase 3 Clinical | Achillion Pharmaceuticals Inc | Hemoglobinuria, Paroxysmal; Renal Insufficiency; Coronavirus Disease 2019 (COVID-19); Glomerulonephritis, Membranoproliferative; Geographic Atrophy; Hepatic Insufficiency; Glomerulonephritis | Details |
This web search service is supported by Google Inc.
A-Z
